Irreversible Airflow Limitation in Elderly Adults with a History of Severe Childhood Asthma – COPD-A, COPD-C or?

Author:

Savran Osman1,Bønnelykke Klaus2,Ulrik Charlotte Suppli1

Affiliation:

1. Copenhagen University Hospital-Hvidovre

2. COPSAC, Copenhagen University Hospital Gentofte

Abstract

Abstract Background According to the GOLD 2023 strategy paper, classification of chronic obstructive pulmonary disease (COPD) may include distinct COPD types. We applied the GOLD classification of COPD-A and COPD-C in a follow-up of a cohort of adults with a history of severe childhood asthma. Methods We performed a 60-year clinical follow-up of adults with a history of severe childhood asthma and a previous stay at an asthma care facility. COPD-A and COPD-C were defined as post-bronchodilator FEV1/FVC < 0.7 and never-smoker or ever smoker, respectively. Factors possibly associated with irreversible airflow limitation, including demographics, dyspnea severity, blood eosinophil count (BEC), and concomitant diseases were examined. Results The final cohort comprised 232 individuals, of whom 30 and 23, respectively, were classified as COPD-A and COPD-C. Compared to those with no airflow limitation, both individuals with COPD-A and COPD-C more often had had at least one exacerbation in the past 12 months (Risk ratio [RR] 1.83 and RR 2.65, respectively). The COPD-C group had significantly higher MRC dyspnea score (p < 0.01) and higher BEC (p < 0.01) compared to those with no airflow limitation. Compared to COPD-C, COPD-A had higher FeNO (mean 29 [SD 28]). Finally, when comparing participants with COPD-A to COPD-C and participants without airflow limitation, the proportion having osteoporosis and depression were more than doubled. Conclusions In late adulthood, one in four with a history of severe asthma in childhood had developed COPD. COPD-A had higher FeNO, while COPD-C was associated with more dyspnea, higher BEC, and also the highest exacerbation risk.

Publisher

Research Square Platform LLC

Reference32 articles.

1. The global burden of asthma: executive summary of the GINA Dissemination Committee report;Masoli M;Allergy,2004

2. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary;Vestbo J;Am J Respir Crit Care Med,2013

3. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2023. Available from: www.ginaasthma.org. Last visited September 30, 2023.

4. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 report. Available from: i>https://goldcopd.org/. Last visited September 30, 2023.

5. Early-Life Origins of Chronic Obstructive Pulmonary Disease;Martinez FD;N Engl J Med,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3